Rhiannon Jenkinson, Director of Science at Charles River, discusses the impact of the Tumor Microenvironment on immune-oncology drug development, and how the immune system can be harnessed to fight cancer. Related Resources Cell-Based Assays for the Tumor Microenvironment In Vitro Immuno-Oncology Assays Immuno-oncology Pharmacodynamic Models Oncology Pharmacology Models
Publication Role of receptor occupancy assays by flow cytometry in drug development (Cytometry B Clin Cytom, 2016) Learn More
